Search   
MSDS  : 7H-Dibenzo(c,g)carbazole
CAS  : 194-59-2
SYNONYMS  : * 7-Aza-7H-dibenzo(c,g)fluorene * 3,4,5,6-Dibenzcarbazol * 3,4,5,6-Dibenzcarbazole * 3,4,5,6-Dibenzocarbazole * 3,4,5,6-Dinaphthacarbazole * 7H-DB(c,g)C
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : HO5600000
CHEMICAL NAME : 7H-Dibenzo(c,g)carbazole
CAS REGISTRY NUMBER : 194-59-2
BEILSTEIN REFERENCE NO. : 0213015
REFERENCE : 5-20-08-00621 (Beilstein Handbook Reference)
LAST UPDATED : 199803
DATA ITEMS CITED : 29
MOLECULAR FORMULA : C20-H13-N
MOLECULAR WEIGHT : 267.34
WISWESSER LINE NOTATION : T D6 C6 B566 MMJ
COMPOUND DESCRIPTOR : Tumorigen
Mutagen
SYNONYMS/TRADE NAMES :
* 7-Aza-7H-dibenzo(c,g)fluorene
* 3,4,5,6-Dibenzcarbazol
* 3,4,5,6-Dibenzcarbazole
* 3,4,5,6-Dibenzocarbazole
* 3,4,5,6-Dinaphthacarbazole
* 7H-DB(c,g)C

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 13 mg/kg
TOXIC EFFECTS :
Liver - other changes
REFERENCE :
BIJOAK Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce
Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- Volume(issue)/page/year:
32,1460,1938

** TUMORIGENIC DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 150 mg/kg/17W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
PRLBA4 Proceedings of the Royal Society of London, Series B: Biological
Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76-
1905- Volume(issue)/page/year: 122,429,1937

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 280 mg/kg/32W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Gastrointestinal - tumors
Liver - tumors
REFERENCE :
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills,
Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year:
4,203,1950

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 99 mg/kg/99W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria
Skin and Appendages - tumors
REFERENCE :
CALEDQ Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1975- Volume(issue)/page/year:
37,337,1987

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 13 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BIJOAK Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce
Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- Volume(issue)/page/year:
32,1460,1938

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 280 mg/kg/32W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Gastrointestinal - tumors
Liver - tumors
REFERENCE :
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills,
Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year:
4,203,1950

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 10 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Lungs, Thorax, or Respiration - tumors
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60,
1940-78. For publisher information, see JJIND8. Volume(issue)/page/year:
1,225,1940

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Implant
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 40 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Tumorigenic - tumors at site of application
REFERENCE :
BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills,
Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year:
6,412,1952

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Implant
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 65 mg/kg/52W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Kidney, Ureter, Bladder - tumors
REFERENCE :
JPBAA7 Journal of Pathology and Bacteriology. (London, UK) V.1-96,
1892-1968. For publisher information, see JPTLAS. Volume(issue)/page/year:
68,561,1954

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intratracheal
SPECIES OBSERVED : Rodent - hamster
DOSE/DURATION : 72 mg/kg/18W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria
Lungs, Thorax, or Respiration - tumors
Lungs, Thorax, or Respiration - bronchiogenic carcinoma
REFERENCE :
JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub.,
1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76-
Volume(issue)/page/year: 3,935,1977

TYPE OF TEST : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 90 mg/kg/23W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Liver - tumors
Skin and Appendages - tumors
REFERENCE :
PRLBA4 Proceedings of the Royal Society of London, Series B: Biological
Sciences. (Royal Soc., 6 Carlton House Terrace, London SW1Y 5AG, UK) V.76-
1905- Volume(issue)/page/year: 122,429,1937

** MUTATION DATA **

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 20 ug/plate
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 198,15,1988

TYPE OF TEST : Micronucleus test
TEST SYSTEM : Human Lymphocyte
DOSE/DURATION : 50 ug/L
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year:
26,109,1995

TYPE OF TEST : DNA adduct
TEST SYSTEM : Human Fibroblast
DOSE/DURATION : 1400 nmol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,4706,1986

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Cells - not otherwise specified
DOSE/DURATION : 10 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,4706,1986

TYPE OF TEST : Mutation in mammalian somatic cells
TEST SYSTEM : Human Fibroblast
DOSE/DURATION : 500 nmol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,4706,1986

TYPE OF TEST : DNA adduct
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 80 umol/kg
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
49,2633,1989

TYPE OF TEST : DNA adduct
ROUTE OF EXPOSURE : Subcutaneous
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 44 umol/kg
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 6,1271,1985

TYPE OF TEST : DNA adduct
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 37 umol/kg
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 8,591,1987

TYPE OF TEST : DNA adduct
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 5 umol/kg
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year:
25,202,1995

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Rodent - hamster Embryo
DOSE/DURATION : 400 nmol/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House,
Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980-
Volume(issue)/page/year: 10,419,1989

*** REVIEWS ***

IARC Cancer Review:Animal Sufficient Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 3,260,1973

IARC Cancer Review:Animal Sufficient Evidence
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 32,315,1983

IARC Cancer Review:Human No Adequate Data
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals
to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210)
V.1- 1972- Volume(issue)/page/year: 32,315,1983

IARC Cancer Review:Group 2B
IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49
Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year:
7,56,1987

TOXICOLOGY REVIEW
85DHAX "Medical and Biologic Effects of Environmental Pollutants Series,"
Washington, DC, National Academy of Sciences, 1972-77
Volume(issue)/page/year: Pc,4,1972

*** OCCUPATIONAL EXPOSURE LIMITS ***

OEL-FRANCE JAN 1993

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat

NTP 7th Annual Report on Carcinogens, 1992 : anticipated to be carcinogen


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,9-acetyl-7-chloro-3-methyl- 62538-90-3
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,9-acetyl-3-methyl- 62538-94-7
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,6-chloro-3-methyl-, hydrochloride 62538-82-3
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,7-chloro-3-methyl-, hydrochloride 62538-83-4
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,3-methyl-, hydrochloride 62538-81-2
9H-Dibenz(b,f)imidazo(1,2-d)(1,4)diazepine,3-methyl-9-propionyl- 62538-91-4
Dibenz(b,f)imidazo(1,2-d)(1,4)oxazepine, 3-methyl-,hydrochloride 62538-79-8
Dibenz(b,f)imidazo(1,2-d)(1,4)thiazepine 62538-84-5
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutyl)-, dichloride 95461-38-4
Dibenz(b,f)imidazo(1,2-d)(1,4)thiazepine, 3-methyl-,hydrochloride 62538-80-1
Dibenz(c,f)indeno(1,2,3-ij)(2,7)naphthyridine 193-40-8
10H-Dibenz(b,e)iodinium, 3,7-bis(dimethylamino)-,salt with N,N'-1,2-ethanediylbis(N-(carboxymethyl)glycine) (1:1) 143578-51-2
10H-Dibenz(b,e)iodinium, 3,7-bis(dimethylamino)-,salt with 2-hydroxy-1,2,3- propanetricarboxylic acid(1:1) 111950-71-1
3H-Dibenz(f,ij)isoquinoline-2,7-dione,4-bromo-3-methyl- 111950-71-1
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine,3a,12b-dihydro-3-phenyl- 85008-74-8
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine-8-ethanamine,N,N-dimethyl-3-phenyl-, monohydrochloride 85008-92-0
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine, 3-phenyl- 85008-92-0
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine-8-propanamine,N,N-dimethyl-3-phenyl-, monohydrochloride 85008-88-4
8H-Dibenz(b,f)isoxazolo(4,5-d)azepine-8-propanamine,3-phenyl-N,N,beta-trimethyl-, monohydrochloride 85008-93-1
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(3-bromo-2-methyl-1-oxopropyl)-, dichloride,hydrate 95461-33-9
Dibenzo(a,e)aceanthrylene-1,2-diol,1,2,3,4-tetrahydro-3,4-epoxy- 95461-33-9
Dibenzo(a,e)aceanthrylene-10,11-diol,10,11,12,13-tetrahydro-12,13-epoxy- 95461-33-9
6H-Dibenzo(b,e)azepin-6-one,5,11-dihydro-11-ethoxy-5-methyl- 88124-27-0
Dibenzo(a,g)biphenylene-3,9-diol,5,6,6a-alpha,6b-beta,11,12,12a-beta,12b-alpha-octahydro- 88124-27-0
Dibenzo(c,g)carbazole 28641-62-5
7H-Dibenzo(a,g)carbazole 207-84-1
13H-Dibenzo(a,i)carbazole 239-64-5
7H-Dibenzo(c,g)carbazole 194-59-2
7H-Dibenzo(a,g)carbazole, 12,13-dihydro- 63077-00-9
7H-Dibenzo(c,g)carbazole, 5,9-dimethyl- 88193-04-8
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(3-bromo-1-oxopropyl)-, dibromide 86641-77-2
7H-Dibenzo(a,g)carbazole, 2-methyl- 63918-57-0
7H-Dibenzo(c,g)carbazole, N-methyl- 27093-62-5
7H-Dibenzo(c,g)carbazole, 3-methyl- 101021-43-6
1H-Dibenzo(c,g)carbazol-2-ol 101021-43-6
1H-Dibenzo(c,g)carbazol-3-ol 101021-43-6
1H-Dibenzo(c,g)carbazol-4-ol 101021-43-6
7H-Dibenzo(c,g)carbazol-2-ol 78448-08-5
7H-Dibenzo(c,g)carbazol-3-ol 78448-07-4
7H-Dibenzo(c,g)carbazol-4-ol 78448-09-6
7H-Dibenzo(c,g)carbazol-13c-ol 78448-09-6
3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane,3,12-bis(3-bromo-1-oxopropyl)-, dichloride 86641-76-1
7H-Dibenzo(c,g)carbazol-13c-ol, 6a,13c-dihydro- 86641-76-1
Dibenzo(b,def)chrysene 189-64-0
Dibenzo(def,mno)chrysene 191-26-4
Dibenzo(def,p)chrysene 191-30-0
Dibenzo(def,mno)chrysene, 6-bromomethyl- 191-30-0
Dibenzo(b,def)chrysene-7-carboxaldehyde 63040-54-0
Dibenzo(def,mno)chrysene-12-carboxaldehyde 63040-55-1
Dibenzo(def,p)chrysene-10-carboxaldehyde 2869-59-2

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net